Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Fuhe Pharmaceutical Group is a prominent Chinese pharmaceutical company headquartered in Suihua, Heilongjiang. Established in the 1990s, the group has grown into a comprehensive enterprise integrating R&D, production, and sales of chemical pharmaceuticals and Traditional Chinese Medicines (TCM). The company's extensive product line includes capsules, tablets, granules, and injections, with a strong focus on cardiovascular, respiratory, and anti-infective therapeutic areas. Fuhe operates several GMP-certified manufacturing bases and maintains a significant presence in the domestic Chinese market through its "Fuhe" brand. The group is also involved in the cultivation of medicinal herbs and the production of pharmaceutical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Fuhe Pharmaceutical Group.